Most Patients With Acute Low-Tone Hearing Loss Have Recovery

WEDNESDAY, April 5, 2023 (HealthDay News) -- For patients with acute low-tone hearing loss (ALHL) without vertigo, partial or complete recovery is reported frequently, although recurrence seems to be relatively common, according to a review published online March 7 in The Laryngoscope.
Ryan J. Huang, M.D., from the Duke University School of Medicine in Durham, North Carolina, and colleagues conducted a scoping review of the literature to examine recovery from hearing loss, recurrence and/or fluctuation of hearing loss, and progression to Meniere disease among patients presenting with ALHL without vertigo. Data were included from 41 studies.
The researchers identified extensive heterogeneity between studies with respect to defining ALHL, treatment methods, and follow-up time. Partial or complete recovery of hearing was reported in the majority of patients (>50 percent) in most of the cohorts (39 of 40), although reports of recurrence were relatively common. Progression to Meniere disease occurred rarely. In six of eight studies, shorter time from onset of symptoms to treatment predicted better hearing outcomes.
"While the literature suggests that the majority of patients with ALHL appear to experience hearing improvement, recurrence and/or fluctuation are common," the authors write. "Additional studies and randomized controlled trials utilizing standardized criteria for diagnosis, study inclusion, and hearing outcome are needed to determine the natural history and ideal treatment for ALHL."
One author disclosed serving on the surgical advisory boards for Med-El and Advanced Bionics.
Related Posts
Un estudio halló que la enfermedad de las encías aumenta el riesgo de deterioro cognitivo
Was this page helpful?
COVID Shots’ Effect Fades, But Boosters Bring Protection Back: Study
MONDAY, Sept. 12, 2022 (HealthDay News) -- Updated COVID-19 booster shots that...
Una terapia con células madre quizá ralentice a la EM mejor que los fármacos, según un estudio
MIÉRCOLES, 28 de diciembre de 2022 (HealthDay News) -- Un nuevo estudio amplía...
Regeneron Says Its Antibody Cocktail Likely Weakened by Omicron Variant
TUESDAY, Nov. 30, 2021 (HealthDay News) -- Regeneron Pharmaceuticals said...